Dr. E’s 84-year-old patient has had type 2 diabetes for 30 years and has been doing great on oral meds and basal insulin. At his last appointment though, his A1c was mysteriously high. How did Dr. E solve the problem?
read more →
Medicare made a big move recently and expanded CGM access for people with type 2 diabetes on insulin, or people with non-insulin treated diabetes who have a history of certain types of hypoglycemic events.
read more →
Dr. E has been wearing the Eversence E3 implantable CGM for about six weeks. He shares his thoughts on the insertion process, accuracy, ease of use, comfort, and the additional unique benefits of the system.
read more →
Watch Dr. E get the Eversense E3 CGM sensor inserted in real time! The E3 is the only fully-implantable sensor on the market, and it also has the longest wear time of any other sensor – 180 days! We’ll go through the features of the E3, the quick outpatient procedure, and important aftercare. (Emotional support teddy bears optional).
read more →
Even though we live in a continuously expanding diabetes tech age, we’re always excited when a product we love gets an upgrade. On December 8, 2022, Dexcom’s G7 CGM got the green light from the FDA. See what the next gen brings!
read more →
If you’re not utilizing your trend arrows and reacting to them, you’re not getting the most out of your CGM. Drs. E+P explain how to dose (or not dose) in response to the direction your trend arrows are pointing. Here’s their advice on how to adjust for highs and lows, along with a trend arrow cheat sheet.
read more →
Spartan Races test an athlete’s physical and mental strength with challenging obstacles like leaping over fire and low crawling in mud under barbed wire. Marlon Blanquart has conquered four of these races, all while managing type 1 diabetes.
read more →
A former diabetes educator shares his experience trying fast-acting insulin Lyumjev in his pump, while monitoring mealtime spikes and overall time in range with his Dexcom CGM.
read more →
The FreeStyle Libre 3 was recently approved by the FDA and has many important new features, including continuous blood sugar readings sent directly to your smartphone, better Bluetooth, improved accuracy, and a smaller, slimmer profile.
read more →
The Eversense E3 implantable CGM was recently approved by the FDA and offers a six-month wear time, the longest of any CGM on the market. Drs. E+P explain how the device works, what the implant procedure is like (they’ve both had it done), and what the unique features are of the system.
read more →